- Report
- November 2023
- 231 Pages
Global
€4767EUR$4,995USD£3,994GBP
- Report
- January 2024
- 95 Pages
United States
€3340EUR$3,500USD£2,799GBP
- Report
- March 2019
- 17 Pages
Global
€9544EUR$10,000USD£7,996GBP
- Report
- March 2019
- 17 Pages
Global
€9544EUR$10,000USD£7,996GBP
- Report
- January 2021
- 144 Pages
China, Global
From €3000EUR$3,367USD£2,602GBP
- Report
- February 2024
- 87 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
- Book
- February 2024
- 592 Pages
Venlafaxine is a medication used to treat depression, anxiety, and panic disorder. It is a serotonin-norepinephrine reuptake inhibitor (SNRI) and is classified as a Central Nervous System (CNS) drug. Venlafaxine works by increasing the levels of serotonin and norepinephrine in the brain, which helps to improve mood and reduce anxiety. It is available in both immediate-release and extended-release formulations. Common side effects include nausea, headache, insomnia, and dry mouth.
Venlafaxine is a widely prescribed medication and is available in generic form. It is marketed by several pharmaceutical companies, including Pfizer, GlaxoSmithKline, and Mylan. It is also available in combination with other medications, such as bupropion and olanzapine. Venlafaxine is available in both brand-name and generic forms, and is available in a variety of dosage forms, including tablets, capsules, and oral solutions. Show Less Read more